This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1994 Aug 17;86(16):1245-7.

doi: 10.1093/jnci/86.16.1245.

N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells

A Mariotti¹, E Marcora, G Bunone, A Costa, U Veronesi, M A Pierotti, G Della Valle

Affiliations

PMID: 8040893
DOI: 10.1093/jnci/86.16.1245

N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells

A Mariotti et al. J Natl Cancer Inst. 1994.

. 1994 Aug 17;86(16):1245-7.

doi: 10.1093/jnci/86.16.1245.

Authors

A Mariotti¹, E Marcora, G Bunone, A Costa, U Veronesi, M A Pierotti, G Della Valle

Affiliation

¹ Dipartimento di Genetica e Microbiologia, Università di Pavia, Italy.

PMID: 8040893
DOI: 10.1093/jnci/86.16.1245

No abstract available

PubMed Disclaimer

Similar articles

Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Di Vinci A, Geido E, Infusini E, Giaretti W. Di Vinci A, et al. Int J Cancer. 1994 Nov 1;59(3):422-6. doi: 10.1002/ijc.2910590322. Int J Cancer. 1994. PMID: 7927952
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG. Ponzoni M, et al. Cancer Res. 1995 Feb 15;55(4):853-61. Cancer Res. 1995. PMID: 7850799
Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.
Lovat PE, Oliverio S, Corazzari M, Rodolfo C, Ranalli M, Goranov B, Melino G, Redfern CP, Piacentini M. Lovat PE, et al. Cancer Res. 2003 Nov 1;63(21):7310-3. Cancer Res. 2003. PMID: 14612528
Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells.
Lovat PE, Corazzari M, Goranov B, Piacentini M, Redfern CP. Lovat PE, et al. Ann N Y Acad Sci. 2004 Dec;1028:81-9. doi: 10.1196/annals.1322.009. Ann N Y Acad Sci. 2004. PMID: 15650234 Review.
The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma.
Lovat PE, Corazzari M, Di Sano F, Piacentini M, Redfern CP. Lovat PE, et al. Cancer Lett. 2005 Oct 18;228(1-2):105-10. doi: 10.1016/j.canlet.2005.01.044. Cancer Lett. 2005. PMID: 15907365 Review.

See all similar articles

Cited by

A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors.
Otterson GA, Lavelle J, Villalona-Calero MA, Shah M, Wei X, Chan KK, Fischer B, Grever M. Otterson GA, et al. Invest New Drugs. 2005 Dec;23(6):555-62. doi: 10.1007/s10637-005-1665-2. Invest New Drugs. 2005. PMID: 16034523 Clinical Trial.
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Norris RE, Minturn JE, Brodeur GM, Maris JM, Adamson PC. Norris RE, et al. Cancer Chemother Pharmacol. 2011 Dec;68(6):1469-75. doi: 10.1007/s00280-011-1623-y. Epub 2011 Apr 12. Cancer Chemother Pharmacol. 2011. PMID: 21484309 Free PMC article.
Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins.
Doldo E, Costanza G, Agostinelli S, Tarquini C, Ferlosio A, Arcuri G, Passeri D, Scioli MG, Orlandi A. Doldo E, et al. Biomed Res Int. 2015;2015:624627. doi: 10.1155/2015/624627. Epub 2015 Mar 24. Biomed Res Int. 2015. PMID: 25879031 Free PMC article. Review.
Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma.
Herrero Martín D, Boro A, Schäfer BW. Herrero Martín D, et al. PLoS One. 2013;8(1):e55072. doi: 10.1371/journal.pone.0055072. Epub 2013 Jan 25. PLoS One. 2013. PMID: 23372815 Free PMC article.
Phase II trial of fenretinide in advanced renal carcinoma.
Vaishampayan U, Heilbrun LK, Parchment RE, Jain V, Zwiebel J, Boinpally RR, LoRusso P, Hussain M. Vaishampayan U, et al. Invest New Drugs. 2005 Mar;23(2):179-85. doi: 10.1007/s10637-005-5864-7. Invest New Drugs. 2005. PMID: 15744595 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information